Abstract. It is well accepted that vascular neoformation can be divided into three main stages (which may be overlapping): (1) changes within the existing vessel, (2) formation of a new channel, (3) maturation of the new vessel.
Introduction
To understand the mechanisms of capillary sprout formation as a result of endothelial cell migration is fundamental to vascularization in many physiological and pathological situations. For example evidence that most capillary growth in the rat heart takes place in the early stages of post natal development 22, 28] was followed by the ndings of concomitant changes in the expression of various growth factors 5, 6] . However this interaction is not fully understood; particularly in the study of endothelial cell growth. There is well documented evidence that results from \in vitro" studies cannot be automatically extrapolated to the situation \in vivo". Indeed transforming growth factor (TGF ) which suppresses the proliferation of endothelial cells in vitro has an overall angiogenic e ect in vivo. 28] .
Capillaries are remarkably stable structures. For example the turnover of endothelial cells in the adult mammalian heart is probably slightly faster than in most other tissues. Nevertheless the cell half-life is estimated to be approximately 300 days 10]. Most of the formation of new vascular material normally constitutes replacement of damaged cells and re-population of denuded areas in the pathological processes such as wound healing.
However, in the development of tumors capillary growth through angiogenesis leads to vascularization of the tumor, providing it with its own blood supply and consequently allowing for rapid growth and metastasis.
It is important to distinguish the main features of vascularization; that is vasculogenesis and angiogenesis. Vasculogenesis is de ned as the formation of new vessels in sites from pluripotent mesenchymal cells (e.g. angioblasts) whereas angiogenesis is de ned as the outgrowth of new vessels from a pre-existing network. We shall be concerned with angiogenesis. Both vasculogenesis and angiogenesis have been documented during prenatal development of mammalian hearts 10, 20, 22] . For example in the case of the rat heart, up to day 10 post-fertilization the endocardium is smooth, and the only mode of oxygen transport is by di usion. This Date: May 15, 1998 . The rst two authors were supported in part by NATO grant CRG-95120. The authors also thank Professor Steven Ford of the Department of Animal Sciences of the Department of Biochemistry for several stimulating discussions and enlightening comments. They likewise acknowledge the helpful discussions with Dr. Pam Jones of St. James University Hospital, Leeds and Dr. Bryan Dixon of Cookridge Hospital, Leeds. 1 is followed by vasculogenesis in the form of sinusoids lined by a very thin endothelium which are located within the spongy musculature. Angiogenesis follows in the form of sprouts emanating from the branches of coronary arteries, starting in the subepicardial layer and proceeding towards the sinuses located in the endomycardium. The newly formed vessels may subsequently regress or persist as capillaries or they may progress to form larger vessels of arterial or venous type. Vascular growth is a complex phenomena involving the mechanisms of angiogenesis. These include mechanical factors in which there is an increased red blood cell -endothelial interaction, as in polycythemia, an increased wall tension as a result of increased capillary pressure and an increased shear stress resulting from increased velocity ow. Energy imbalance is another factor wherein there is a prolonged imbalance between the perfusion capabilities of blood vessels and the metabolic requirements of tissue changes in oxygenation may have a major triggering and controlling element. In ammatory processes may also be associated with the activation of endothelial cells and possibly platelets; both of which express the adhesion molecules for monocytes. Monocytes are a possible major source of angiogenic growth factors. For a discussion of these issues we refer the reader to 1, 9, 25, 27] .
The precise mechanisms of vascular growth are complex and not well understood. The role of various growth factors has been considered by 7, 12, 13] . The e ects vary depending on the environment and the concentration of these factors with di erent results obtained under in vivo and in vitro conditions.
The most often cited angiogenic peptides which are e ective both in vivo and in vitro are acidic and basic broblast growth factors (FGF), vascular endothelial growth factor (VEGF) and vascular permeability factor (VPF), transforming growth factor alpha (TGF ) and related epidermal growth factor (EGF).
The factors VEGF, VPF and PD-ECGF (platelet-derived endothelial all growth factor) are mitogenic factors highly speci c for endothelial cells and VEGF may be induced by hypoxia. In addition to these factors which are endothelial cell mitogens, there are angiogenic factors which are not mitogenic (e.g. angiogenic) or are even inhibitory to endothelial cell proliferation in vitro. For example these include transforming growth factor beta (TGF ) and tumor necrosis factor (TNF ).
In addition to the angiogenic factors, vascular growth can be further modi ed and regulated by local geometric conditions; endothelial cell size and shape and the location of other cell types such as smooth muscle cells, pericytes, platelets, macrophages and mast cells.
The complexity of the endothelial growth process and the large number of apparently redundant angiogenic factors may be an indication 12] of the vital importance of the process itself. Indeed the ne tuning and interaction of the above systems maintains this delicate balance for the optimal arrangement of vascular geometry.
At the present time it appears to be a formidable task to develop a complete mathematical model of angiogenesis which incorporates all of the above complex processes. It is desirable nevertheless to attempt to describe a portion of this process. This paper therefore concentrates on the importance of some of the angiogenic factors involved. In particular it focuses on the angiogenic factors associated with the neovascular phase of solid tumor growth.
To this end we rst discuss the major morphological components of the stable vessel which are potentially involved in the process of angiogenesis. The most prominent are the at endothelial cells themselves. Typically two endothelial cells are required to encircle the capillary Lumen. These cells are not to be regarded as simply a passive lining of the micro-vessels, but rather as a composite in a large and extremely active endocrine organ. The capillary as a whole is wrapped in a basement membrane which is only a fraction of the thickness of the endothelial cells. The basement membrane also covers infrequently occurring pericytes which are similar to smooth muscle cells. Pericytes possibly contribute to the regularization of the vessel size and control the proliferation of endothelial cells. This regulation requires cell-to-cell contact -and maybe mediated by TGF , which suppresses endothelial cell proliferation.
Macrophages and activated platelets are also important and sometimes major sources of angiogenic factors involved in all stages of vessel formation. 3, 27, 29] .
It is now well accepted, 21, 25] , vascular neoformation can be divided into three main stages (which may be overlapping):
1. changes within the existing vessel.
2. formation of a new channel. 3. maturation of the new vessel. The entire process is nicely illustrated schematically in Figures 1, 2 which are taken from 14, 24] respectively. This paper concentrates on stage 1, while the modeling of stages 2 and 3 will be the subjects of further work.
In stage 1 one of the primary events is the dilation of the vessel. This is followed by the activation of the endothelial cells which as a result of their stretching show an increased sensitivity to various growth factors. The endothelial cells respond by secreting plasminogen activator and a variety of proteolytic enzymes which dissolve the extra-cellular matrix where the growth factors such as FGF are stored.
Subsequently the basement membrane becomes disrupted and local extravasation takes place. Leaked brin and its products serve as a provisional matrix for future growth. Also, the activated endothelial cells start to synthesis new DNA while they are still in the parent vessel. Additional growth factors are provided by nearby activated platelets and macrophages.
In regard to tumor growth angiogenesis is initiated by the release of angiogenic factors from the tumor. In response to this stimulus activated endothelial cells in nearby capillaries appear to thicken and ngerlike protrusions can be observed on the abluminal surface 2, 21]. Cell associated proteases degrade the basement membrane allowing the EC's to accumulate in the region where the concentrations of TAF reaches a threshold 21]. The vessel wall dilates as the EC's aggregate to form sprouts. The EC's as described above release proteolytic enzymes which dissolve the basal lamina and ECM enabling the capillary sprouts to grow towards the tumor 11].
With this motivating background we now focus on the development of mathematical models of the rst stage of angiogenesis. The plan of this paper is as follows:
2 18] . In this model the authors concentrate on the role of haptotaxis to regulate all movement due to the release of bronectin which increases cell-to-matrix adhesiveness and also serves as a provisional matrix for future growth. The model is based on reaction-di usion mechanisms and capillary sprout formation is accounted for through Turing -di usion driven instability 16, 30] .
Here a somewhat di erent-point-of view is o ered, based on the idea of reinforced random walks 4]. This idea was developed and exploited in 19] to describe the movement of living organisms that deposit a nondi usible substance (signal) which modi es the local environment for subsequent movement. The particular organisms studied are the micro bacteria particularly myxococus fulvius and dictyostelium discoidium. In the continuum limit Othmer and Stevens 19] derive a system of evolutionary equations which may exhibit nite-time blow up of solutions, decay to a spatially constant solution, or nonconstant, piecewise constant solutions (aggregation). In 15] the authors have provided detailed rigorous and semi-rigorous arguments which support the existence of aggregation. We believe that aggregation is an important component of sprout formation.
In the next section we discuss the enzyme kinetics we wish to employ in our model. In the subsequent section, we apply the ideas of random walk discussed above to the vascular wall.
2.1. Enzyme Kinetics. In order to better understand how the angiogenic factor acts on the endothelial cells, we consider a simpli ed version of Figure 1 . That is, we consider that each cell has a certain number of receptors to which the angiogenic factor (ligands) bind. The bound molecules (intermediaries) in turn stimulate the cell to produce proteolitic enzyme and form new receptors.
We model this process as follows:
?! Q where V denotes the angiogenic factor (substrate), R denotes some receptor site on the endothelial cell wall, RV is the intermediary, C is the proteolytic enzyme produced by this reaction, R 0 is an intermediary ligand-like molecule which then exits the cell to produce a receptor of the original type R at the cell surface and nally Q is a product produced as the protease degrades the laminar wall. The point of view here is that the receptors at the surface of the cell function the same way an enzyme functions in classical enzymatic catalysis.
We shall take a somewhat simpli ed version of this mechanism as follows; We make two hypotheses about this system: H1 The reaction proceeds so rapidly that @@ t 0: This is essentially the original Michaelis-Menton hypothesis. H2 r(x; t) is proportional to (x; t) and on the time scale of the above hypothesis, we can write r(x; 0) (x; t): From the rst two equations and the second hypothesis we can write r(x; t) +`(x; t) = r(x; 0) (x; t): since there is no intermediate present initially. Using this and the consequence of setting`t = 0; we obtain, after some algebra In this paper we shall rst replace (2. The rational behind this is that we want to test the mechanism for the e ect of the auto-production mechanism for our full model before proceeding to the full set of equations (2.1.4.) This test is useful because we can think of (2.1.5) as a Michaelis-Menton type kinetic equation. We could also imagine that proteolytic enzyme production could be set o in a cell by radiation or some other external stimulus other than by a chemical bullet such as angiogenic factors.
More importantly, the system that employs (2.1.5) is much easier to analize than the one that includes (2.1.4). This is true even in the simple subcases for which = = 0: Therefore, we shall simply carry out a few numerical experiments for our full system when we employ (2.1.4).
2.2. Random Walk. In order to understand the idea behind the notion of reinforced random walks, we consider the parent capillary wall to be a one-dimensional lattice with endothelial cells (assumed to be a mono layer of equal size and shape) equally spaced and in non-overlapping contact located at reference points nh along the x-axis.
At rst we imagine a distribution of endothelial cells at lattice points x n = nh on the real axis. We let n ( ) be the transition probability/unit time for a one-step move of an endothelial cell at site n to site n + 1 or n ? 1. Let n (t) be the probability density distribution of the endothelial cells at position n at time t:
Then the time rate of change of n (t) is governed by the master equation
That is, n will be augmented by cells moving from the positions (n 1)h to nh and diminished by cells moving from nh to either(n + 1)h or (n ? 1)h: The quantity (^ + n (W) +^ ? n (W)) ?1 is the mean waiting time at site n.
It is convenient to think of this conditional probability density as the density of endothelial cells. The point of view adopted here is the same as in quantum mechanics where an electron can be thought of as a probability density or else as a \ cloud of negative charge."
The transition probability rates^ n ( ) depend on control substances which we have denoted by W and are de ned on the lattice at 1 2 -step size. The control substances W are very general and can include all the enzymes which are generated by the growth factors described above i.e., (FGF), (VEGF), (TGF ), (TGF ) etc. As remarked above, in this paper, we concentrate on the important role of secreted bronectin and proteolytic enzyme which dissolves the ECM and ruptures the basement membrane. Denote the density of bronectin by f and the concentration of proteolytic enzyme by c. The control substance W is represented as the vector of components. W = (:::W ?n? 1 2 ; W ?n ; W ?n+ While the basic model (2.2.1) can be exploited 19] to describe many aspects of organism dynamics it gives no restriction on the transition rates at a site and there is no correlation between transition rates to right or left.
Suppose, as suggested in 19] , that the decision of \when to move" is independent of the decision of \where to move". Then the mean waiting time of the process is constant across the lattice. Hence the transitionŝ n may be suitably scaled and normalized. Let the scaled and normalized transition rates be N n (W) and depend on W only at the nearest neighbors 
where (x; t) now denotes endothelial cell density and^ =^ (w) =^ (w(f; c)).
The production of bronectin is modeled through a logistic growth term f(1 ? f) together with a term describing the up-take of bronectin by the EC, f . This yields the additional dynamical equation and initial condition: @f c(x; 0) = c 0 (x) 0 where we are now using (2.1.5) instead of (2.1.4) as explained in the preceding section. The system is closed by assuming no-ux boundary conditions at x = 0;`, i.e. @ @x ln ^ = 0 at x = 0;`: (2.2.10) To complete the model we suppose the transition probability rate function^ to be factored aŝ We shall say that the sensitivity factors (2.2.13),(2.2.15) are \ power law sensitivity factors". The choice of the transition probability^ adopted here is to provide a measure of how responsive the EC are to various growth factors. In the case of tumor growth this would be for example due to the EC's enzymatic responses to one or more of the tumor angiogenesis factors (TAF). The model is in this regard very exible and other choices of^ can be adopted, having other degrees of sensitivity depending on the particular angiogenic process to be modeled. For example in 19] it is supposed that a signal is transduced via a receptor R which binds with the signal w and that the response is proportional to the fraction of receptors occupied. The binding reaction can be written as
where Rw] denotes the receptor -signal complex. If binding comes rapidly to equilibrium on the time scale of the evolution of and w; then for the local sensing 19] choose a transition probabilitŷ
where is a constant that incorporates the total number of receptors and k ?1 =k 1 .
In their work on modeling capillary endothelial cell-extracellular matrix interactions in wound healing, the authors in 17] used a haptotaxic transition probability.
where C and k are constants and m is the brillar ECM density.
In the context of the present work, we are primarily interested in the mechanism of capillary sprouting from the parent vessel as a result of aggregation of endothelial cells. It is therefore reasonable to suppose that a primary mechanism for this is due to the sensitivity of the EC to angiogenic growth factors and consequently on the form of the transition probabilities^ (c; f). Therefore in Section 4 of this paper we shall consider^ (c; f) given by^ This corresponds to an initial endothelial cell density which is a small (in ") perturbation about its mean value. Furthermore \blow up" occurs at the points ? 2m?1 N ; T where 0 < m < N+1 2 . These \blow-up" points may be thought of as initiating sites of capillary sprouts.
Alternatively if a = 0 ? ( ? ) < 0 then it can be shown (see 15] that (3.1.8) has solutions which " collapse". Indeed, one nds, the \same" solutions: Of course this solution is formally the same as when a > 0 but the constant c is now always negative and hence decays to a constant as t ! +1: That is, capillary sprouts do not form. For this to occur we must have ( ? ) > 0 with su cient haptotatic sensitivity. This means that if < so that bronectin is being consumed, then < 0 also, so that the the haptotatic sensitivity factor is positive and large, i.e., there is motility of bronectin into the region of high endothelial cell concentration, at least for low levels of bronectin.
Having determined the structure of in terms of the behavior of we see that the concentration of the proteolytic enzyme c is given by Here we know that sprouts will form (\blow up" case) and from (3.1.16)-(3.1.17) we see that c(x; t) rapidly increases whereas f(x; t) decreases to zero in nite time. This is in accord with the observation that enzyme release is greatest at the penetration site where the bronectin is weakest.
Conversely if a < 0, then sprouts do not form (the collapse case) and c(x; t) tends to zero and f(x; t) rapidly increases. This is also in good agreement with observations.
It is clear then that the simple model consisting of the rst two equations in (3.1.1) and the approximate equation (3.1.2) together with the corresponding boundary condition, even without proliferation of bronectin and chemotactic sensitivity is able to reproduce the early stages of capillary formation initiating the angiogenesis process.
Angiogenic factor driven case. In this section we consider the full system (2.2.23)-(2.2.24). We no-
tice that angiogenic factor is always decreasing while proteolytic enzyme could increase or decrease. Therefore as long as the proteolyic enzyme concentration is smaller than , it will increase at the expense of angiogenic factor. In this case, we then havê 
where is a rate constant for EC production and 1 is some maximal EC density which cannot be exceeded by endothelial cells. Notice that in (3.3.1) we are suggesting that endothelial cells will proliferate or be consumed according as the proteolytic factor exceeds or falls below its initial value. However, in the absence of enzymatic factor, we would not expect any "conversion" of cells. Therefore, we reject this model. However, in (3.3.2), no EC proliferation will occur unless the factor exceeds its initial value although if the proteolytic enzymatic factor falls below its initial value no EC (or proteolytic enzyme) will be consumed.
In both (3.3.1) and (3.3.2) the underlying assumption (in so far as the coe cient of is concerned) is that the rate of production of endothelial cells or proteolytic enzyme is a second order reaction, at least for small values of : However, it could be that this production is only rst order. That is, the production of EC is sensitive to the presence of excess proteolytic enzymatic factor but not its amount. In this case, we would replace (3. where sgn(x) denotes the sign of x if x 6 = 0 and is zero otherwise. order, it seems worthwhile to at least consider calculations based on (3.3.3).
Since it is easy to modify our programs to include mitogenic e ects, and since including such terms in our calculations here would only mask the e ects of the random walk model, we shall not include any computations in this paper based on the equations in this remark. However, we will include the e ects of mitogenesis when we consider the full model which will include branching of the capillary sprouts into the ECM in a forthcoming work. 
19).
The idea here is to present to the vascular wall an initial non constant proteolytic enzyme pro le (which may have caused a short time earlier by the cell's response to one of the angiogenic factors) and then follow the change in EC density, enzyme concentration and laminar thickness via the dynamical equations (2.2.21). We have taken the initial data such that (4.1.1) holds initially. Our numerical computations require that x ; c x ; f x vanish at x = 0; and consequently, (4. The di erence is that we have now taken = 0:1995 so that the initial enzyme concentration is very small and the sensitivity factor c x =c is now very large near the ends of the interval. In fact this ratio is very much larger near the ends than it is near the center. This gives the EC a greater \incentive" to move toward the center the further from the center they are. The total amount of enzyme is the same. We see the formation of a double peak. What is happening here is the following: If the cells are su ciently \starved" of enzyme near the ends, they will tend to \walk" su ciently fast toward the center of the capillary to form a double peak. Notice that in Figures 3.1c, 3 .2c, the basement lamina is strongly degraded near the center of the interval.
1c. With the choices given in the gure caption for Figures 4.1, 4.2 Da < 0: (For these choices, we took = 0 but + < 0:) Since there is no aggregation of endothelial cells here, we would say that the system is unfavorable for angiogenesis. 2. In Figure 5 we use (2.2.21)and (4.1.1) with (2.2.11), (2.2.15) and with = 1: This set of gures is included to test the full power of the Michaeles-Menton like terms in the simpli ed model. Again we notice that if the initial enzyme distribution is \blunt", the EC distribution is unimodal in x ( Figure 5.1c) while if the enzyme distribution is initially sharp (c x =c large near the ends) then the EC concentration develops a bimodal (two peaked) pro le in x ( Figure 5.2c) . The bimodal space (x) section pro les occurring in the various plots are somewhat di cult to explain mathematically but an explanation along the lines of 15] can be given in terms of the so called \hodograph" plane. This need not further concern us, but we should be aware of the mathematical phenomenon.
As far as a biological explanation is concerned, it may be that these pro les are not realizable in nature. 
We began our numerical study with the same set of initial conditions for the simpli ed system (3.2.2) with (2.2.11) and (2.2.14). ( 3.] below.)
3. In Figures 6.1 , we have plotted the EC density, the enzyme density, the bronectin density and the angiogenic growth factor density for a \blunt" initial distribution of angiogenic growth factor while for Figures 6.2, a more peaked initial pro le of angiogenic growth factor was used, the total amount being the same in both cases. (Compare Figures 6.1d, 6 .2d.) Although the angiogenic variable v(x; t) does not appear in the EC equation, a unimodal or bimodal distribution of endothelial cells again occurs if the sensitivity factor (v x =v) has a small variation or a large variation respectively. Next we experimented with the system (2.2.23) with (2.2.11) and (2.2.14). 4. In Figures 7.1 and 7 .2 we xed the initial variation but now examined what happens when we change the bronectin parameters. When = = 0:4 we have a unimodal distribution of EC (Figure 7 .1a) but when = = 0:1 we obtain a bimodal distribution of EC (Figure 7 .2a). The behavior of the bronectin, enzyme and growth factor concentrations are unchanged except for the rates of growth and decay. of 5. In Figures 7.3 and 7 .4 we experimented with the e ect of the constant k 3 (= ) in our full MichaelisMenton mechanism (2.1.2). Notice ( Figure 7 .3b, 7.4b) that the proteolytic enzyme is being consumed rather growing (Figure 7 .1b, 7.2b) as we would expect. Notice also the bimodal distribution of EC concentration in Figure 7 .4b which is due to the combined e ect of a smaller = ratio and a more peaked initial distribution of v(x; t): Finally, we conducted experiments with (2. , a bimodal distribution forms in the EC density which then coalesces into a unimodal distribution, but in the latter two gures, the EC density becomes very focused. 6b. In Figures 8.2b, 8 .3b, as the enzyme density drops to zero, it forms a prow shaped region with a ridge (only half the gure is shown in 8.3b) which is more pronounced in the latter gure. This is due to the fact that the enzyme is being consumed more rapidly in the latter case. Figures 8.1d, 8.2d and 8.3d , the form of decay of the growth factor is roughly the same.
Cautionary note on numerics
Numerical computations with these models can sometimes give misleading information. In our program we used a simple explicit marching procedure. For the standard heat equation, this procedure will be stable if ( x) 2 =D t is smaller than 0:5: However, for nonlinear problems of the type considered here, this criterion must be modi ed and the modi ed criterion checked at each time step. While we did not do this here since it slows running time, we reran the program at various values of this ratio. Features of the plots that persisted are presumed to be present in the actual solution while features that depend on the step sizes are assumed to be artifacts of the numerics.
As a check on our numerics, we calculated
which, in the absence of cell proliferation should be constant. in place of the rst equation in (2.2.8) We make no assumption on the signs of the constants (i) j ; i or the di erences j ? j : All other constants will be assumed to be positive or perhaps zero.
Naturally, we still have the master equation (2.2.7) and the boundary condition (2.2.10). However, there will now need to be prescribed several initial conditions in place of the second equation in each of (2.2.9), (2.2.8).
Rather than look at (2.2.7) together with (6.1.1) and (6.1.2), let consider (2.2.7) together with the following simpli ed versions of (6.1.1) and (6. (1)
where denotes the coe cient of x in the middle term. Now, provided the sum is not zero and we chose (x; 0) such that
must satisfy L tt + ( x t ) x = xxt (6.1.9) which is the same as (3.1.8) with a = : From our prior work with (6.1.9) we know that there will be solutions which blow up in nite time if a > 0 and that if a < 0, solutions will collapse to a constant in in nite time. We say therefore that the system (2.2.7), (6.1.1), (6.1.2) is favorable for angiogenesis if and only if
i > :0 (6.1.10) Thus, we shall say that a single a chemotactic or haptotatic factor is said to be favorable for angiogenesis if and only if (k) In section 2 we have considered the situation in which we have a single chemical agent and a single haptotatic agent. We assumed that the chemotactic agent was favorable for angiogenesis. The haptotatic agent will be favorable for angiogenesis if ? > 0: Of course if one agent is favorable for angiogenesis and the other is not, then angiogenesis cannot occur (according to this model at least) unless the sum is positive.
It follows from (6.1.5)-(6.1.6) that f j (x; t) = f j (x; 0)e Thus, if a > 0; and blows up in nite time, then the same will be true for and the concentrations or densities of all the proteolytic enzymatic or haptotatic factors for which (i) j > 0 while for those factors for which the rate constants (i) j < 0; th concentrations or densities will collapse to zero in nite time. Of course it is not as easy to solve (2.2.7), (6.1.1), (6.1.2). We must resort to numerical computations in general. Corresponding to each of these we would have a pair of ordinary di erential equations of the form given in (2.1.4) for each such mechanism. Since we cannot produce exact solutions (even for a simpli ed model as discussed Section 3. On the other hand, the mechanism(s) described in (2.1.2)(resp. (6.2.1)) are only overall mechanisms.
Summary
In this paper we have set out to describe the essential features of angiogenesis in general and to tumor angiogenesis in particular.
We have proposed a new mathematical model based on two essential ideas: A. The notion that endothelial cell migration is essentially a \di usive" process based on the notion of reinforced random walks. An essential ingredient in this notion is the incorporation of transition probabilities which \reinforce" the walking. These transition probabilities are taken to be functionally dependent on the proteolytic enzymes which stimulate cell movement and upon variations in the density of bronectin in the vessel wall. B. The proteolytic enzymes themselves are regarded as the products of a catalytic \reaction" of angiogenic factors with the cell of Michaelis-Menton type. The \catalyst" for this reaction is taken to be the receptor molecules which project from the cell interior through the membrane. We analyzed this model as follows. B-1. We examined the simple sub-case of B] in which proteolytic enzyme is self generated in response to some non-chemical stimulus of unknown origin. However, the production rate equation for the enzyme was taken to be of saturation form. This ordinary di erential equation was then combined with a \production" equation for bronectin coupled with the random walk partial di erential equation in A]. B-2. We then examined the full model described in B] in which the two classical Michaelis-Menton ordinary di erential equations were combined with a \production" equation for bronectin coupled with the random walk partial di erential equation in A]. Both the models B-1] and B-2] showed that when the initial total variation of the concentration distribution of enzyme ( B-1]) or growth factor (B-2]) was small, the endothelial cells aggregate to form a unimodal distribution. However, when the total initial variation of either concentration was large, the initial aggregation was bimodal which then coalesced into a unimodal distribution. In either case, the numerical experiments indicate a breakdown in bronectin as proteolitic enzyme forms and is then consumed.
8. Discussion-Future Work The processes involved in gaining a fuller understanding of angiogenesis is complex and not well understood. For example, we have not addressed the e ects on our results if haptotatic saturation of bronectin is taken into account as well as its proliferation. Nor have we addressed the role of the mast cells, the macrophage cells and the pericyte cells. These aspects will be the subject of further work. In addition there is also the fundamental problem of linking the capillary sprout model to modeling angiogenesis within the ECM. Work in this direction is in progress and will be reported in due course. Figure 3 with the exception that we now take = 0:1995: 
